PDT Partners’s Agios Pharmaceuticals AGIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-8,485
Closed -$279K 732
2024
Q4
$279K Sell
8,485
-48,250
-85% -$1.59M 0.02% 596
2024
Q3
$2.52M Sell
56,735
-18,545
-25% -$824K 0.22% 153
2024
Q2
$3.25M Sell
75,280
-18,124
-19% -$782K 0.31% 95
2024
Q1
$2.73M Buy
93,404
+8,251
+10% +$241K 0.26% 131
2023
Q4
$1.9M Buy
85,153
+38,951
+84% +$867K 0.21% 151
2023
Q3
$1.14M Buy
46,202
+2,792
+6% +$69.1K 0.14% 255
2023
Q2
$1.23M Buy
43,410
+17,193
+66% +$487K 0.17% 201
2023
Q1
$602K Sell
26,217
-37,408
-59% -$859K 0.08% 364
2022
Q4
$1.79M Sell
63,625
-9,153
-13% -$257K 0.29% 93
2022
Q3
$2.06M Sell
72,778
-43,754
-38% -$1.24M 0.31% 64
2022
Q2
$2.58M Buy
116,532
+84,258
+261% +$1.87M 0.23% 118
2022
Q1
$939K Buy
+32,274
New +$939K 0.08% 397
2021
Q2
Sell
-71,700
Closed -$3.7M 784
2021
Q1
$3.7M Sell
71,700
-40,878
-36% -$2.11M 0.27% 147
2020
Q4
$4.88M Buy
112,578
+6,278
+6% +$272K 0.33% 132
2020
Q3
$3.72M Buy
106,300
+29,300
+38% +$1.03M 0.25% 157
2020
Q2
$4.12M Sell
77,000
-15,434
-17% -$825K 0.28% 136
2020
Q1
$3.28M Sell
92,434
-2,898
-3% -$103K 0.26% 118
2019
Q4
$4.55M Buy
95,332
+22,232
+30% +$1.06M 0.28% 117
2019
Q3
$2.37M Sell
73,100
-21
-0% -$680 0.14% 182
2019
Q2
$3.65M Buy
+73,121
New +$3.65M 0.22% 133
2018
Q3
Sell
-66,200
Closed -$5.58M 469
2018
Q2
$5.58M Sell
66,200
-43,836
-40% -$3.69M 0.21% 150
2018
Q1
$9M Sell
110,036
-41,232
-27% -$3.37M 0.3% 115
2017
Q4
$8.65M Sell
151,268
-34,833
-19% -$1.99M 0.25% 137
2017
Q3
$12.4M Buy
186,101
+201
+0.1% +$13.4K 0.41% 83
2017
Q2
$9.57M Buy
+185,900
New +$9.57M 0.38% 88
2015
Q4
Sell
-19,200
Closed -$1.36M 408
2015
Q3
$1.36M Buy
19,200
+5,900
+44% +$416K 0.03% 616
2015
Q2
$1.48M Buy
13,300
+1,100
+9% +$122K 0.04% 583
2015
Q1
$1.15M Hold
12,200
0.03% 739
2014
Q4
$1.37M Sell
12,200
-7,700
-39% -$863K 0.13% 172
2014
Q3
$1.22M Buy
+19,900
New +$1.22M 0.03% 564